Nifedipine Tablet, Film Coated, Extended Release
Product Images NDC 50268-598

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50268-598). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (597 15 30mg)

30 (597 15 30mg)
This is a description of a medication package for NIFEdipine extended-release tablets. The tablets are for prescription use only and come in a pack of 50 unit-dose tablets. The dosage of each tablet is 33 mg of NIFEdipine. The package includes instructions for use and storage. The medication should be kept at a controlled room temperature and protected from moisture and light. It should also be kept out of reach of children. The tablets are manufactured by Akire and distributed by Avkare.*
FDA Label Image

60 (598 15 60mg)

60 (598 15 60mg)
This is a medication with 50 extended-release tablets of NIFEdipine, USP, in a unit dose package. The tablets are meant for oral use only and each has 6 mg of NIFEdipine. The recommended dosage instructions must be found in the inserted documentation or package prescribing. It is important to store the product between 20°-25°C (66°-77°F) and protect it from moisture, humidity, and light. The manufacturer is AVKARE. No further information is available.*
FDA Label Image

90 (599 15 90mg)

90 (599 15 90mg)
This is a prescription drug with the NDC 50268-599-15. It contains NIFEdipine and is available in extended-release tablets, USP. Each unit dose contains 5x10 tablets. The dosage should be followed according to the prescribing package and the tablets should be stored at a temperature between 20°C-25°C. The drug should be kept away from children. The drug is manufactured by Avkare, and the expiry date is March 2019.*
FDA Label Image

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.